Starbucks (SBUX) is all set to announce its fiscal 2Q17 earnings after the market closes on April 27, 2017.
Wall Street is quite positive on Supervalu’s (SVU) stock. Analysts are expecting a 45% rise in SVU’s stock price over the next 12 months.
After falling around 30% in 2016, Supervalu’s (SVU) stock continues to be in the red in 2017.
After adjusting for certain one-time charges, third quarter net earnings (from continuing operations) stood at $14 million, or $0.05 per diluted share.
The retail food segment, which accounts for 35% of Supervalu’s (SVU) top line, has been the company’s worst-performing segment.
Supervalu (SVU) has failed to impress investors with its financial performance over the last several quarters.
Supervalu (SVU) is scheduled to report its fiscal 4Q17 and full fiscal 2017 results on Tuesday, April 27, 2017.
JNJ has received “buy” ratings from ~38% of its analysts, while ~62% of the brokerage firms have rated the company as a “hold.”
On April 20, JNJ stock was trading ~11.5% above its 52-week low of $109.32 on December 7, 2016, and ~5.5% below its 52-week high of $129.00 on March 15, 2017.
In 1Q17, priority platform sales in JNJ’s Medical Device segment grew ~6.5%, while the electrophysiology and advanced surgery businesses registered double-digit sales growth.
In 1Q17, Johnson & Johnson’s (JNJ) Medical Device segment revenues came in at ~$6.3 billion, as compared to $6.1 billion in 1Q16.
On April 18, JNJ released its 1Q17 earnings. After the announcement, the stock fell about 3% from its closing price of $125.72 on April 17.
CL’s management expects its gross margin to reach the higher end of its projected growth range of 75–125 basis points in 2017.
About 13.0% of analysts have recommended a “buy” for CL stock, while 87.0% have recommended a “hold” for the stock.
As of April 20, Colgate-Palmolive (CL) was trading at a 12-month forward PE ratio of 25.1x, which is higher than SPX’s 18.4x and XLP’s 21.3x.
Analysts expect Colgate-Palmolive (CL) to post revenue of $3.8 billion in 1Q17, which would represent a YoY (year-over-year) growth of 0.8%.
CL’s organic sales in its North American segment remained flat in 4Q16. Volume gains in toothpaste were offset by a fall in toothbrushes and liquid hand soap.
Colgate-Palmolive is slated to report its 1Q17 results on Friday, April 28. Analysts expect CL to report adjusted EPS of $0.66 per share—a YoY growth of 4.8%
SWN’s median target price from these Wall Street analyst recommendations is $10.00, which is ~37% higher than its April 19, 2017, closing price of $7.31.
On December 31, 2016, Southwestern Energy (SWN) had ~503 million common shares outstanding.